X-Linked Retinitis Pigmentosa (XLRP)
Symptoms, Doctors, Treatments, Advances & More

X-Linked Retinitis Pigmentosa (XLRP) Overview

Save information for later
Sign Up

Learn About X-Linked Retinitis Pigmentosa (XLRP)

View Main Condition: Retinitis Pigmentosa

What is the definition of X-Linked Retinitis Pigmentosa (XLRP)?
X-linked retinitis pigmentosa is a type of inherited eye disorder that affects the retina, causing progressive vision loss. X-linked retinitis pigmentosa is classified as non-syndromic because it occurs by itself instead of as part of other syndromes.
What are the symptoms of X-Linked Retinitis Pigmentosa (XLRP)?
Symptoms of X-linked retinitis pigmentosa include a loss of night vision in childhood; blind spots in the side, or peripheral, vision; tunnel vision; loss of central vision; and, eventually, blindness.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for X-Linked Retinitis Pigmentosa (XLRP)?
Treatment for X-linked retinitis pigmentosa involves the use of gene therapy made from adeno-associated viral vectors.
Who are the top X-Linked Retinitis Pigmentosa (XLRP) Local Doctors?
Elite in X-Linked Retinitis Pigmentosa (XLRP)
Elite in X-Linked Retinitis Pigmentosa (XLRP)
Referral may be required

UNC Kittner Eye Center

2226 Nelson Hwy Ste 200, 
Chapel Hill, NC 
984-974-2020
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Alessandro Iannaccone is an Ophthalmologist practicing medicine in Chapel Hill, North Carolina. Dr. Iannaccone is rated as an Elite provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Retinitis Pigmentosa, Retinopathy Pigmentary Mental Retardation, Usher Syndrome Type 2A, and Late-Onset Retinal Degeneration. Dr. Iannaccone is currently accepting new patients.

Elite in X-Linked Retinitis Pigmentosa (XLRP)
Dr. Byron L. Lam
Ophthalmology
Elite in X-Linked Retinitis Pigmentosa (XLRP)
Dr. Byron L. Lam
Ophthalmology
Referral may be required
900 Northwest 17th Street, 
Miami, FL 
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Byron Lam is an Ophthalmologist practicing medicine in Miami, Florida. Dr. Lam is rated as an Elite provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses X-Linked Retinitis Pigmentosa (XLRP), Retinitis Pigmentosa, Optic Nerve Atrophy, Vitrectomy, and Nerve Decompression. Dr. Lam is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in X-Linked Retinitis Pigmentosa (XLRP)
Dr. Abigail T. Fahim
Ophthalmology
Elite in X-Linked Retinitis Pigmentosa (XLRP)
Dr. Abigail T. Fahim
Ophthalmology
Referral may be required

Kellogg Eye Center

1000 Wall St, Elevator B Floor 2, 
Ann Arbor, MI 
734-763-5874
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Abigail Fahim is an Ophthalmologist practicing medicine in Ann Arbor, Michigan. She has been practicing medicine for over 17 years. Dr. Fahim is rated as an Elite provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses X-Linked Retinitis Pigmentosa (XLRP), Retinitis Pigmentosa, Retinopathy Pigmentary Mental Retardation, and Usher Syndrome Type 2A. Dr. Fahim is board certified in Ophthalmology. Dr. Fahim is currently accepting new patients.

View All Doctors
What are the latest X-Linked Retinitis Pigmentosa (XLRP) Clinical Trials?
An Open-label, Single-center, Dose-escalation Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intraocular Administration of FT-002 in Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa.
An Open-label, Single-center, Dose-escalation Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intraocular Administration of FT-002 in Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa.
Enrollment Status: Recruiting
Publish Date: May 24, 2023
Intervention Type: Genetic
Study Phase: Early Phase 1

Summary: A clinical trial of gene therapy for patients with X-linked retinitis pigmentosa (XLRP).

Match to trials
Find the right clinical trials for you in under a minute
Get started
View All Clinical Trials